SEC Form 4 · accession 0001209191-18-018938
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daphne Quimi
Officer — SVP, Finance
Period of report
Mar 9, 2018
Accepted (ET)
Mar 12, 2018 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 9, 2018 | M | 8,750 | $5.96 | A | 73,082 | D | |
| Common stock | Mar 9, 2018 | S | 8,750 | $15.00 | D | 64,332 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $5.96 | Mar 9, 2018 | M | 8,750 | D | — | Jan 19, 2021 | Common stock | 8,750 | 0 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.
- F2All of the options were fully vested and exercisable as of March 9, 2018.